Search by Drug Name or NDC
NDC 71594-0706-12 FIRSTCARE DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE 30; 12.5 mg/1; mg/1 Details
FIRSTCARE DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE 30; 12.5 mg/1; mg/1
FIRSTCARE DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE is a ORAL TABLET, CHEWABLE in the HUMAN OTC DRUG category. It is labeled and distributed by USpharma Ltd. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE.
Product Information
NDC | 71594-0706 |
---|---|
Product ID | 71594-706_d7adbbe1-e7fd-3a12-e053-2995a90a35e1 |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | FIRSTCARE DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | dextromethorphan hydrobromide, doxylamine succinate |
Product Type | HUMAN OTC DRUG |
Dosage Form | TABLET, CHEWABLE |
Route | ORAL |
Active Ingredient Strength | 30; 12.5 |
Active Ingredient Units | mg/1; mg/1 |
Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE |
Labeler Name | USpharma Ltd |
Pharmaceutical Class | Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA] |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH FINAL |
Application Number | part341 |
Listing Certified Through | 2023-12-31 |
Package
Package Images

NDC 71594-0706-12 (71594070612)
NDC Package Code | 71594-706-12 |
---|---|
Billing NDC | 71594070612 |
Package | 30 TABLET, CHEWABLE in 1 BOTTLE (71594-706-12) |
Marketing Start Date | 2022-02-10 |
NDC Exclude Flag | N |
Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL 0bbcd796-6d71-4ca3-b03a-b07b6da4dc4b Details
Active ingredients (in each chewable tablet)
Uses
- temporarily relieves cough due to minor throat and bronchial irritation as may occur with a cold
- temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
- runny nose
- sneezing
- itchy, watery eyes
- itching of the nose or throat
- controls the impulse to cough to help you sleep
Warnings
Do not use
- to sedate a child or to make a child sleepy
- if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
Ask a doctor before use if you have
- trouble urinating due to an enlarged prostate gland
- glaucoma
- a cough that occurs with too much phlegm (mucus)
- a breathing problem or chronic cough that lasts or as occurs with smoking, asthma, chronic bronchitis or emphysema
When using this product
- do not use more than directed
- marked drowsiness may occur
- avoid alcoholic drinks
- alcohol, sedatives, and tranquilizers may increase drowsiness
- be careful when driving a motor vehicle or operating machinery
- excitability may occur, especially in children
Directions
Other information
Inactive ingredients
anhydrous citric acid, calcium gluconate monohydrate, carnauba wax, coconut oil, corn syrup, croscarmellose sodium, crospovidone, FD&C red no. 40, flavor, hydroxypropyl betadex, maltitol solution, mannitol, microcrystalline cellulose, noncrystallizing sorbitol solution, powered milk, sorbitol, starch, sucralose, sucrose
PRINCIPAL DISPLAY PANEL
INGREDIENTS AND APPEARANCE
FIRSTCARE DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE
dextromethorphan hydrobromide, doxylamine succinate tablet, chewable |
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
Labeler - USpharma Ltd (080664601) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
USpharma Ltd | 080664601 | manufacture(71594-706) |
Revised: 2/2022
Document Id: d7adbbe1-e7fd-3a12-e053-2995a90a35e1
Set id: 0bbcd796-6d71-4ca3-b03a-b07b6da4dc4b
Version: 1
Effective Time: 20220210